NASA has signed an agreement with a California-based startup to develop and market a nasal spray for motion sickness, the U.S. space agency said on Friday. NASA will work with privately owned Epiomed Therapeutics of Irvine, California, on the nasal spray, which has been shown to be a fast-acting treatment for motion sickness.
